Figure 3个  Table 4个

    • Table 1.  Global results on the whole group and sub-groups.

    •

      Table 2.  Compared characteristics of the whole group of patients and HCV RNA ∓ sub-groups.

    •

      Table 3.  Percentages of drugs used in mono, multi therapy and all together.

    •

      Table 4.  Comparison of the medians of VL at first sampling (1) and second sampling (2) in true positive treated patients with (+) or without (-) cycloferon in monotherapy versus dual therapy.